Search research articles
Contact Us
Filters
Showing results (301-310 of 561) with videos related to
Page
of 57
Sort By:
Bladder Cancer (Amsterdam, Netherlands)
|
August 22, 2017
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy
Marco Moschini, Francesco Soria, Martin Susani, et al.
Annals of Surgical Oncology
|
March 29, 2019
Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy
Paolo Dell'Oglio, Zhe Tian, Sami-Ramzi Leyh-Bannurah, et al.
World Journal of Urology
|
July 23, 2015
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy
Ettore Di Trapani, Rafael Sanchez-Salas, Giorgio Gandaglia, et al.
BJU International
|
September 24, 2017
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration
Andrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
European Urology Oncology
|
June 20, 2026
Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients
Mehdi Kardoust Parizi, David D'Andrea, Benjamin Pradere, et al.
Clinical Genitourinary Cancer
|
May 12, 2024
Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel
Valentina Tateo, Antonio Cigliola, Chiara Mercinelli, et al.
Journal of Clinical Medicine
|
May 11, 2024
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature Review
Roberto Contieri, Renate Pichler, Francesco Del Giudice, et al.
Cancers
|
May 30, 2019
<sup>18</sup>F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study
Fabio Zattoni, Elena Incerti, Fabrizio Dal Moro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2022
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial
Giuseppe Basile, Marco Bandini, Ewan A Gibb, et al.
World Journal of Urology
|
March 30, 2025
Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis
Luca Afferi, Beate Jahn, Amar H Kelkar, et al.
Page
of 57
Search research articles
Search
Showing results (301-310 of 561) with videos related to
Sort By:
Page
of 57
Bladder Cancer (Amsterdam, Netherlands)
|
August 22, 2017
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy
Marco Moschini, Francesco Soria, Martin Susani, et al.
Annals of Surgical Oncology
|
March 29, 2019
Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy
Paolo Dell'Oglio, Zhe Tian, Sami-Ramzi Leyh-Bannurah, et al.
World Journal of Urology
|
July 23, 2015
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy
Ettore Di Trapani, Rafael Sanchez-Salas, Giorgio Gandaglia, et al.
BJU International
|
September 24, 2017
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration
Andrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
European Urology Oncology
|
June 20, 2026
Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients
Mehdi Kardoust Parizi, David D'Andrea, Benjamin Pradere, et al.
Clinical Genitourinary Cancer
|
May 12, 2024
Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel
Valentina Tateo, Antonio Cigliola, Chiara Mercinelli, et al.
Journal of Clinical Medicine
|
May 11, 2024
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature Review
Roberto Contieri, Renate Pichler, Francesco Del Giudice, et al.
Cancers
|
May 30, 2019
<sup>18</sup>F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study
Fabio Zattoni, Elena Incerti, Fabrizio Dal Moro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2022
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial
Giuseppe Basile, Marco Bandini, Ewan A Gibb, et al.
World Journal of Urology
|
March 30, 2025
Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis
Luca Afferi, Beate Jahn, Amar H Kelkar, et al.
Page
of 57